The forecasted data indicates a consistent decline in erythromycin imports to France from 2024 to 2028, moving from 52.63 to 42.22 thousand kilograms. This trend suggests a year-on-year reduction in import volume. With the compound annual growth rate (CAGR) also depicting a downward trajectory, this decrease highlights potential shifts in demand, increasing self-sufficiency, or alternative sourcing strategies by 2028.
Future trends to watch for include:
- Potential advancements in domestic production capabilities.
- Emerging substitutes impacting erythromycin demand.
- Regulatory changes influencing import practices.
